Gene transfer to the kidney can be achieved with various DNA vectors, resulting in transgene expression in glomerular or tubular districts. Controlling transgene destination is desirable for targeting defined renal cells for specific therapeutic purposes. We previously showed that injection of polyplexes into the rat renal artery resulted in transfection of proximal tubular cells. To investigate whether this process involves glomerular filtration of the DNA-containing particles, fluorescent polyethylenimine polyplexes were prepared, containing fluoresceinated poly-L-lysine. This allowed visualization of the route of the particles into the kidney. Our polyplexes were filtered through the glomerulus, since fluorescent proxiKeywords: kidney; non-viral gene delivery; fluorescent complexes: glomerular filtration barrier; laser light scattering; -galactosidase Genetic renal diseases could in principle be corrected by somatic gene therapy. Different districts of the kidney are affected by different pathologies; for example, autosomal dominant polycystic kidney disease causes the formation of liquid-filled cysts along the whole tubule, 1 while Alport syndrome affects the glomerulus. 2 Therapeutic gene transfer must therefore be tailored to ensure expression of the transgene in the appropriate cell type. A number of viral, as well as non-viral, approaches have been used to transfer genes to the kidney, leading to expression of the transgene in the tubule, 3 in the glomerulus, 4,5 or in renal vessels. 6 In these cases, access to the kidney was achieved via direct injection into the left renal artery, but intrapelvic injections have also been employed, leading to transgene expression in the papilla and medulla, 3 or in the outer medulla. 7 In our previous work, we showed that DNA complexed with branched 25 kDa PEI at 10 equivalents (eq) of amino to phosphate (N/P) groups is able to transfect proximal tubular cells following injection into the rat renal artery. Conversely, transfection efficiency of DNA complexed to 5 N/P eq of PEI, or to cationic lipids such as DOTAP, was significantly lower. 8 Given the anatomical complexity of the Correspondence: L Monaco, Dibit, San Raffaele Scientific Institute, Via Olgettina, 58, 20132 Milan, Italy Received 12 April 1999; accepted 13 October 1999 mal tubuli were observed. Conversely, fluorescent lipopolyplexes containing the cationic lipid DOTAP were never observed in tubular cells. Size measurements by laser light scattering showed that the mean diameter of polyplexes (93 nm) was smaller than that of lipopolyplexes (160 nm). The size of the transfecting particles is therefore a key parameter in this process, as expected by the constraints imposed by the glomerular filtration barrier. This information is relevant, in view of modulating the physico-chemical properties of DNA complexes for optimal transgene expression in tubular cells. Gene Therapy (2000) 7, 279-285. kidney in the present work we investigated the route of these complexes in this organ, in an attempt to correlate ...